Clinical Paradigms of Disease Resolution: Biological Differentiation between the Cure of Pathological Processes and the Reversal of Structural Damage

The medical community has historically distinguished between the resolution of acute illness and the long-term management of chronic disease. As lifestyle medicineLifestyle medicine uses everyday behavior — food, movement, sleep, stress, not smoking — to prevent and treat disease. has matured into a formal clinical discipline, it has exposed a critical gap in medical taxonomy: the failure to clearly differentiate between the cure of an active pathological process and the reversalREVERSAL compared moderate and intensive statin therapy, using intravascular ultrasound to measure what happened to coronary plaque. of structural damage produced by that process. Within dominant clinical paradigms, most chronic diseases are treated through symptom control, risk reduction, and delay of complications rather than through complete elimination of all underlying biological drivers.¹ Nevertheless, a growing body of empirical evidence—most prominently from the longitudinal work of Dean Ornish and Caldwell Esselstyn—demonstrates that coronary artery diseaseCoronary artery disease is plaque buildup in the arteries feeding the heart muscle. (CAD), a major cause of global mortality, can in some patients show halted progression, improved vascular function, plaque stabilizationPlaque stabilization is making an existing plaque less likely to crack open — thickening its cap, shrinking its greasy core, and calming the inflammation inside it., and even modest regression when cardiovascular risk factorsA risk factor is something that raises your chance of developing a disease — high cholesterol particles, high blood pressure, smoking, diabetes, family history. are intensively controlled through comprehensive lifestyle and risk-factor intervention.² This state can reasonably be described, within the conceptual framework developed here, as a functional or pathophysiological “cure” of active disease, even though it does not invariably result in complete restoration of normal vascular anatomy or elimination of pre-existing structural injury.⁵ This use of “cure,” however, is not standard terminology in contemporary cardiovascular guidelines.

The conceptual challenge of distinguishing cure from reversal is well illustrated by the dermatological example of severe acne vulgaris. In acne, the disease process consists of inflammationInflammation is your immune system's response to injury or something it treats as an invader. It brings swelling, heat, and cleanup cells. associated with follicular hyperkeratinization, excess sebum production, Cutibacterium acnes activity, and host inflammatory responses.⁷ When treated effectively, this process can resolve, resulting in the cessation of new lesionsIn cardiology, a lesion refers to a discrete area of atherosclerotic plaque narrowing a coronary artery, typically described by the percentage of luminal obstruction it causes. The article describes four residual lesions too small in vessel diameter to accept a stent after the most critical one was treated.. Yet many patients are left with permanent atrophic or hypertrophic scars—structural alterations of the skin that no longer represent active disease.¹⁰ This distinction provides a clinically useful analogy and conceptual framework for cardiovascular medicine: a patient may achieve substantial suppression or stabilization of active atherosclerotic disease and experience substantially reduced risk of acute coronary events while still retaining calcified plaquesCalcified plaque is the hardened, calcium-filled part of a plaque. It shows up brightly on a CT scan, which is what a calcium scan measures. or ischemic limitations that represent historical damage and may coexist with residual disease activity and cardiovascular risk.⁶

Taxonomic Definitions in Chronic Disease Management

To navigate chronic disease resolution with precision, clinicians must distinguish the status of the pathological process from the condition of the affected organ’s structure. For purposes of the conceptual framework proposed in this paper, the following terms distinguish suppression of an active pathological process from regression of established structural pathology. These definitions should not be interpreted as universally accepted clinical definitions. A cure within this framework denotes durable suppression or elimination of the dominant biological processes driving disease, with restoration toward physiological homeostasis. In chronic cardiometabolic disease, continued control of causal risk factors may still be required to maintain this state.¹⁴ Reversal, in contrast, refers to regression of measurable disease markers—such as hyperglycemiaAbnormally elevated blood glucose concentration; included as one of the modifiable risk factors in the PDAY scoring system because it accelerates arterial lesion progression in adolescents and young adults. or arterial stenosisStenosis is narrowing — usually described as a percentage, like a 70 percent blockage.—toward or below clinically defined thresholds, typically requiring sustained behavioral adherenceAdherence means actually taking your medicine the way it was prescribed, day after day. to prevent recurrence.³

Clinical State | Pathophysiological Status | Required Intervention Post-Resolution | Primary Biological Characteristic
Cure | Dominant disease-driving processes durably suppressed or eliminated | Continued risk-factor control may be necessary | Absence or marked suppression of measurable active disease drivers
Reversal | Pathological markers regressed | Sustained lifestyle adherence | Reduction of measurable pathology
Remission | Markers below diagnostic threshold | Continuous monitoring | Absence of currently detectable disease activity or expression without assurance of permanent eradication
Palliative | Symptoms and disease burden managed; underlying disease may persist | Ongoing supportive treatment | Relief without curative intent

This distinction is particularly relevant in type 2 diabetesDiabetes is a condition where blood sugar stays too high, either because the body makes too little insulin or because it stops responding to the insulin it makes. mellitus (T2D). Remission is defined as an A1C below 6.5% for at least three months without pharmacologic therapy, yet the condition is rarely labeled a cure because genetic susceptibility and residual beta-cell dysfunctionImpaired capacity of the insulin-secreting beta cells of the pancreatic islets to produce sufficient insulin in response to rising blood glucose; in type 2 diabetes, prolonged metabolic stress can cause irreversible beta-cell loss that limits the degree of disease reversal possible. persist.²² International expert consensus therefore favors the term “remission” rather than “cure.”²² Environmental stressors, such as weight regain, can reactivate the disease process.¹⁵ Similarly, in CAD, patients may achieve biological stability in which plaquePlaque is the buildup of cholesterol, immune cells, scar tissue, and calcium inside an artery wall. inflammation and rupture risk are substantially reduced, even though calcified or fibrotic remnants of prior disease remain.⁶

The Dermatological Model: Curing the Process versus Reversing the Scar

The analogy between acne and atherosclerosisAtherosclerosis is the disease behind most heart attacks and many strokes. Cholesterol particles get stuck in the wall of an artery, the body sends immune cells to clean up, and over years that mess hardens into plaque. is biologically informative because both disorders involve mechanisms of inflammation-driven tissue remodeling. Acne targets the pilosebaceous unitThe anatomical structure consisting of a hair follicle and its associated sebaceous (oil) gland; in acne vulgaris, excess sebum production, follicular keratin plugging, and bacterial activity within this unit trigger the inflammation that can ultimately scar the skin., where Cutibacterium acnes can contribute to immune cascades that may culminate in follicular rupture and dermal injury.⁹ When treated with retinoids, antibiotics, or hormonal modulation, the active inflammatory process can resolve or enter sustained remission as pathogenic mechanisms are suppressed.⁷

Despite resolution of the active inflammatory process, structural sequelae often remain. These scars are classified by collagen dynamics:

Atrophic scars (ice‑pick, boxcar, rolling) result from collagen loss and dermal matrix destruction during intense inflammation.⁸
Hypertrophic scars and keloids reflect excessive collagen deposition, sometimes extending beyond the original lesion.⁸

These residual structural changes may exert lasting psychological and functional effects long after the active disease process has resolved.¹¹ Analogously, individuals with stabilized CAD may retain fixed stenoses or myocardial scars that impair perfusion despite substantial reduction in plaque instability and associated inflammatory activity.⁵ Thus, suppressing or resolving an inflammatory disease process is biologically more achievable than reversing the structural damage it leaves behind.

The Evidence for Cardiovascular DiseaseCardiovascular disease is the umbrella term for problems with the heart and blood vessels, including heart attacks, strokes, and blocked leg arteries. Resolution: Ornish and Esselstyn Paradigms

Contrary to the belief that CAD is an inevitable consequence of aging, extensive clinical research demonstrates that atherosclerosis is a multifactorial disease strongly influenced by modifiable metabolic and lifestyle risk factors, and that its progression can be substantially slowed and, in some selected populations receiving intensive intervention, may be halted or partially reversed.¹² This conclusion is supported by decades of peer-reviewed investigation.

The Ornish Lifestyle Heart Trial

Dean Ornish provided important early randomized evidence that coronary atherosclerosis progression could, in some participants, be halted or modestly reversed without lipid-lowering drugs.² Using quantitative coronary arteriographyA computer-assisted technique that measures the diameter of coronary artery segments from X-ray angiographic images, providing objective, numerical data on the degree of stenosis and plaque burden over time. and positron emission tomographyPositron emission tomography, or PET, uses a mildly radioactive tracer to show which tissues are metabolically busy., the Lifestyle Heart TrialThe Lifestyle Heart Trial, led by Dean Ornish, was a small randomized study testing an intensive lifestyle intervention — very low-fat plant-based diet, exercise, stress management, and group support — using serial coronary angiography; the intervention group's measured arterial narrowing improved slightly while controls worsened, but technical limitations of angiography, reference-segment narrow… evaluated the effects of a comprehensive intervention including a low-fat, whole-food, plant-based dietA plant-based, or plant-predominant, diet is built mostly around vegetables, fruit, beans, whole grains, nuts, and seeds, with animal foods limited or absent., moderate exercise, stress management, and social support.² Eighty-two percent of participants in the intervention arm demonstrated measurable regression in coronary atherosclerosis at one year.² At five years, this group exhibited further average angiographic regressionAngiographic regression refers to a measurable decrease in the size of a coronary artery blockage as seen on X-ray imaging of the coronary arteries; the article cites the Lifestyle Heart Trial as demonstrating that intensive plant-based diet and lifestyle changes can produce this effect. and significantly fewer cardiac eventsClinically significant heart-related occurrences—including myocardial infarction, unstable angina, and cardiac death—used as outcome endpoints in cardiovascular trials. than controls receiving standard dietary advice.²³

The Esselstyn Protocol and Endothelial Stabilization

Caldwell Esselstyn’s work emphasized nutritional primacy in restoring endothelial functionThe ability of the inner lining of blood vessels to regulate vascular tone, inflammation, and clotting; healthy endothelial cells release nitric oxide to keep arteries relaxed and resistant to plaque formation..⁴ By eliminating animal products and added oils, his protocol aims to normalize nitric oxide bioavailabilityThe degree to which the endothelium can produce and maintain adequate levels of nitric oxide, a signaling molecule that keeps blood vessels dilated, inhibits platelet clumping, and prevents inflammatory cells from adhering to the arterial wall. and suppress endothelial inflammation.¹² Long-term observational follow-up of patients with advanced CAD demonstrated a very low rate of recurrent major cardiovascular events among adherent participants.¹³ These findings are clinically notable but should be interpreted cautiously because the evidence is observational rather than derived from a randomized controlled trialA randomized controlled trial assigns people to a treatment or a comparison group purely by chance, then follows both groups.. Esselstyn has proposed that very low LDLLDL, or low-density lipoprotein, is the main particle that carries cholesterol through your blood — and the main one that gets stuck in artery walls. levels together with improved endothelial function may markedly suppress the biological processes responsible for atherosclerotic progression.¹²

Biological Mechanisms Underlying Disease Stabilization

Lifestyle-mediated risk reduction and disease stabilization reflect coordinated biochemical shifts rather than isolated pharmacologic effects. Endothelial nitric oxideNitric oxide is a gas your blood vessel lining makes to tell the vessel to relax and widen. restoration improves vasodilation, inhibits leukocyte adhesionThe process by which white blood cells attach to the endothelial surface of blood vessels, a key early step in atherogenesis; nitric oxide and an intact glycocalyx normally suppress this adhesion., and reduces thrombogenicity.¹² Some studies have shown that high-fat meals can acutely impair endothelial function, whereas nitrate-rich plant foods can enhance nitric oxide bioavailability.¹²

Trimethylamine N-oxide (TMAOTMAO is a compound your gut bacteria produce from nutrients found in red meat, eggs, and some fish. Higher blood levels have been linked to heart disease.) has emerged as a diet-related biomarkerA biomarker is something measurable in the body that tells you about health or disease — a lab value, a scan result, a blood pressure reading. associated with increased cardiovascular risk.¹⁷ TMAO production depends on gut microbial metabolism of dietary precursors including carnitineCarnitine is a nutrient found mostly in red meat. Your body also makes some on its own. and cholineCholine is a nutrient found in eggs, red meat, and liver. Your body genuinely needs it, especially for the brain., which are present in varying amounts in both animal-derived and plant-derived foods, with carnitine particularly abundant in red meatRed meat includes beef, pork, and lamb. and choline present in several animal and plant sources. Individuals adhering to strict plant-based diets demonstrate markedly reduced TMAO generation, although whether lowering TMAO itself independently mediates cardiovascular event reduction remains uncertain.¹⁷

Why Disease Stabilization Outpaces Structural Reversal

While inflammatory atherogenesisAtherogenesis is the step-by-step process of a plaque forming. can respond to intensive modification of metabolic risk factors, structural damage exhibits biological inertiaThe tendency of established structural damage—such as calcified plaques or myocardial scar tissue—to persist even after the active disease process driving that damage has been halted, because the biochemical and cellular remodeling involved is largely irreversible.. Plaque calcificationA process in which calcium phosphate crystals are deposited within atherosclerotic plaques, driven by osteogenic-like differentiation of vascular smooth muscle cells; calcified plaques are structurally stable but largely irreversible even when active disease is suppressed. represents a regulated, osteogenic-like process involving, among other mechanisms, vascular smooth muscle cellSmooth muscle cells make up the middle layer of an artery and control how much the vessel tightens or relaxes. phenotypic differentiation.⁵ Early lipid-rich plaquesAn atherosclerotic lesion whose core is dominated by cholesterol esters and inflammatory lipids rather than calcium or fibrous tissue; the article notes that such plaques are highly responsive to intensive treatment and that the dramatic 65-percentage-point regression at the diagonal branch origin is consistent with reversal of a lipid-rich lesion. are more amenable to regression, whereas mature calcified lesions often persist despite disease quiescence.¹⁶ Genomic studies demonstrate that early and advanced plaques are governed by distinct regulatory networks, limiting reversibility in late-stage disease.¹⁸

Myocardial infarctionSee Heart Attack for the full entry. further illustrates this principle: necrotic myocardiumThe myocardium is the muscular wall of the heart — the part that actually squeezes to push blood around your body. is replaced by fibrotic scar tissue that lacks normal myocardial contractile function.¹⁹ Comprehensive secondary preventionSecondary prevention is treating someone who has already had a heart attack, stroke, or stent, to stop the next one., including lifestyle intervention, can reduce the risk of subsequent infarction but cannot readily regenerate lost myocardium, leading to chronic ischemic limitations.²⁰

Residual Cardiovascular Risk

Residual cardiovascular riskThe continuing probability of major cardiovascular events that remains even after recognized risk factors such as LDL cholesterol and blood pressure have been brought under control, attributable to persistent calcification, arterial stiffness, low-grade inflammation, and incomplete plaque stabilization. refers to the continuing risk of cardiovascular events despite treatment and control of major recognized risk factors.⁶ Contributors include persistent calcificationCalcification is when calcium gets deposited into a plaque, turning part of it hard and bony., arterial stiffnessArterial stiffness is a measure of how much an artery's wall resists expansion with each pulse of blood; it increases with age as elastin is lost and collagen accumulates, and manifests clinically as a rising systolic blood pressure alongside a falling or stable diastolic blood pressure after about age 60., incomplete plaque stabilization, and low-grade inflammation.⁶ These risks are potentially attributable to both persistent structural abnormalities and ongoing biological processes, including residual inflammatory, thrombotic, lipid-related, and metabolic risk. In this respect, persistent cardiovascular damage partially parallels residual structural sequelae in other chronic diseases.

Comparative Disease Models

This active-disease-versus-residual-damage distinction recurs throughout medicine. In T2D, substantial loss of ectopic hepatic and pancreatic fat can restore insulin sensitivityInsulin sensitivity is how well your cells respond to insulin. It is the opposite of insulin resistance. and improve beta-cell function in some patients, yet prolonged disease may result in irreversible beta-cell loss.³ In hypertensionHypertension is the medical term for high blood pressure., blood pressureBlood pressure is the force of blood pushing against your artery walls. It is written as two numbers, like 120/80. The top number is the pressure when your heart squeezes, the bottom is when it relaxes. normalization may not fully reverse left ventricular hypertrophyPathological thickening of the muscular wall of the left ventricle, most commonly caused by sustained high blood pressure forcing the heart to work harder; even after blood pressure is normalized, some degree of structural hypertrophy may persist. or nephrosclerosis once structural remodeling has occurred.²¹

Disease | Mechanism of Disease Control/Resolution | Permanent Structural Residual
Severe Acne | Anti-inflammatory, keratinization-directed, antimicrobial, and/or hormonal therapy | Dermal scarring
Heart Disease | Comprehensive risk-factor modification, including dietary improvement, exercise, smokingSmoking damages the lining of your blood vessels, raises blood pressure, makes blood clot more easily, and speeds up plaque growth. cessation when applicable, stress management, and evidence-based medical therapy | Calcified plaques, myocardial fibrosis
Type 2 Diabetes | Substantial weight lossWeight loss means reducing body fat, whether through food changes, exercise, medication, or surgery., reduction of ectopic liver/pancreatic fat, and restoration of metabolic function | Beta-cell loss
Hypertension | Blood-pressure control through dietary modification, physical activity, weight management, sodium reduction, and antihypertensiveAn antihypertensive is any drug used to lower high blood pressure. The article distinguishes antihypertensives — which became widely used from the 1970s onward — from statins, noting that blood-pressure drugs contributed to coronary mortality decline well before statin therapy was available. therapy when indicated | LV hypertrophy, nephrosclerosis

Conclusion

Coronary arteryAn artery is a blood vessel that carries blood away from the heart to the rest of the body. disease is not necessarily an inexorably progressive condition. Intensive lifestyle and risk-factor intervention can halt progression in some patients, promote plaque stabilization, improve vascular function, and in selected cases produce measurable regression of coronary atherosclerosis.² However, successful suppression of disease activity does not guarantee reversal of structural injury. As with resolved inflammatory acne leaving dermal scars, the stabilized heart may retain calcified lesions, myocardial scar, fixed stenoses, or other structural sequelae of prior disease.⁵ If “cure” is defined narrowly as durable control or resolution of the active pathological process rather than restoration of pristine anatomy or permanent elimination of susceptibility, these findings provide a biological basis for considering the concept of a functional or pathophysiological cure. This terminology, however, extends beyond the conventional language of current cardiovascular guidelines and should not be interpreted as meaning that established CAD requires no continuing prevention, monitoring, or treatment. This reality underscores the urgency of early intervention: the most effective strategy is to suppress the disease process before irreversible structural damage develops.¹⁶ The future of medicine lies not in managing inevitable decline, but in applying effective disease-modifying interventions early enough to prevent permanent damage from forming.

References

1. Can we say “cure”? J Eval Clin Pract. Accessed via PubMed Central.
2. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary atherosclerosis? The Lifestyle Heart Trial. Lancet. 1990;336(8708):129-133.
3. Joslin Diabetes Center. Can type 2 diabetes be reversed? Accessed online.
4. Esselstyn CB Jr, Gendy G, Doyle J, Golubic M, Roizen MF. A way to reverse CAD? J Fam Pract. 2014;63(7):356-364.
5. Demer LL, Tintut Y. Calcification: a physiologic defense? In: Inflammatory Atherosclerosis. NCBI Bookshelf.
6. Libby P. Residual cardiovascular risk—Is inflammation the primary cause? Am J Cardiol. Accessed via PubMed Central.
7. Fabbrocini G, Annunziata MC, D’Arco V, et al. Acne scarring: pathogenesis, evaluation, and treatment options. Clin Cosmet Investig Dermatol. Accessed via PubMed Central.
8. Goodman GJ, Baron JA. Acne scars: pathogenesis, classification and treatment. Dermatol Surg. Accessed via PubMed Central.
9. Tan J, Bhate K. Acne vulgaris and the epidermal barrier. Clin Dermatol. Accessed via PubMed Central.
10. DermNet NZ. Acne scarring. https://dermnetnz.org.
11. Tan JK, Bhate K. The psychological impact of acne scarring. Medicine Today.
12. Esselstyn CB Jr. Resolving the coronary artery disease epidemic through plant-based nutrition. Prev Cardiol. Accessed via PubMed Central.
13. Esselstyn CB Jr, et al. Long-term outcomes of plant-based nutrition in coronary artery disease. J Fam Pract.
14. Beyond Type 1. Diabetes remission vs cure vs reversal. Accessed online.
15. Liv Hospital. Can type 2 diabetes be reversed? Accessed online.
16. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Mechanisms and clinical consequences of vascular calcification. Lancet. Accessed via PubMed Central.
17. Tang WHW, Hazen SL. Microbiome, trimethylamine N-oxide, and cardiovascular risk. Circ Res. Accessed via PubMed Central.
18. Fisher EA, et al. Distinct mechanisms of early versus late atherosclerosis regression. Icahn School of Medicine at Mount Sinai.
19. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction. Circulation. Accessed via PubMed Central.
20. Velazquez EJ, et al. Outcomes in ischemic cardiomyopathy. N Engl J Med. Accessed via PubMed Central.
21. Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage. Hypertension. Accessed via PubMed Central.
22. Riddle MC, Cefalu WT, Evans PH, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care. 2021;44(10):2438-2444.
23. Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001-2007.